CANDRIAM S.C.A. – Mirati Therapeutics, Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$46.27M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+4.04%
quarter
Mirati Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +11.48% | 68.21K shares | 6.37M | $69.84 | 662.50K |
Q2 2022 | share | Increase | +17.27% | 87.51K shares | -1.77M | $67.13 | 594.28K |
Q1 2022 | share | Increase | +2.90% | 14.29K shares | -30.57M | $82.22 | 506.77K |
Q4 2021 | share | Increase | +28.51% | 109.26K shares | 4.44M | $148.23 | 492.48K |
Q3 2021 | share | Increase | +10.89% | 37.62K shares | 11.96M | $176.91 | 383.21K |
Q2 2021 | share | Increase | +82.76% | 156.49K shares | 15.92M | $161.53 | 345.59K |
Q1 2021 | share | Increase | 0.00% | 2 shares | -1.64M | $171.3 | 189.1K |
Q4 2020 | share | Increase | +42.03% | 55.96K shares | 19.42M | $219.64 | 189.09K |
Q3 2020 | share | Increase | +20.97% | 23.08K shares | 9.54M | $166.05 | 133.13K |
Q2 2020 | share | Increase | +10.81% | 10.73K shares | 55K | $114.17 | 110.05K |
Q1 2020 | share | 0.00% | 0 shares | -288K | $76.87 | 99.32K | |
Q4 2019 | share | Decrease | -18.79% | -22.97K shares | 3.27M | $128.86 | 99.32K |
Q3 2019 | share | Decrease | -22.10% | -34.7K shares | -6.57M | $77.91 | 122.3K |
Q2 2019 | share | Increase | +38.94% | 44K shares | 7.81M | $103 | 157K |
Q1 2019 | share | Decrease | -46.45% | -98K shares | -667K | $73.3 | 113K |
Q4 2018 | share | Increase | +9.90% | 19K shares | -93K | $42.42 | 211K |
Q3 2018 | share | Increase | +107.12% | 99.3K shares | 4.47M | $47.1 | 192K |
Q2 2018 | share | Increase | 0.00% | 92.7K shares | 4.57M | $49.3 | 92.7K |
Q3 2016 | share | Decrease | -100.00% | -70K shares | -382K | $6.61 | 0 |
Q2 2016 | share | Decrease | -32.69% | -34K shares | -1.83M | $5.46 | 70K |
Q1 2016 | share | Decrease | -9.57% | -11K shares | -1.42M | $21.4 | 104K |